• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OSTEOTECH, INC (SUBSIDIARY OF MEDTRONIC) GRAFTON DBM; FILLER, BONE VOID, OSTEOINDUCTION (W/O HUMAN GROWTH FACTOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OSTEOTECH, INC (SUBSIDIARY OF MEDTRONIC) GRAFTON DBM; FILLER, BONE VOID, OSTEOINDUCTION (W/O HUMAN GROWTH FACTOR) Back to Search Results
Model Number T43105
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Purulent Discharge (1812); Erythema (1840); Headache (1880)
Event Date 04/25/2014
Event Type  Injury  
Event Description
It was reported that a (b)(6) male patient received allograft bone void filler during a ¿left knee arthroscopy with removal of loose ocd (osteochondritis dissecans) lesion; chondroplasty of the patella and trochlea; open anteromedialization tibial tubercle with distalization 8mm (3 x 4.5 mm low profile cortical screws); bone grafting at tibial tubercle defect site; open excision medial patellar exostosis; open repair patellar sided mpfl (medial patellofemoral ligament) / medial retinaculum." approximately one month later, the patient returned to the er with pus-like drainage from the incision complaining of feeling feverish, erythema and headache.The patient was admitted to the hospital that same day and underwent an open debridement drainage and irrigation.Patient was started on antibiotics.Two days later, the patient was returned to surgery for incision and drainage.Patient was started on additional antibiotics.Another two days later, the patient was again returned to surgery for incision and drainage.The graft remains in the patient.The patient was discharged from the hospital approximately 5 weeks after his readmission.
 
Manufacturer Narrative
(b)(4).All donor records and manufacturing records relative to the subject graft were reviewed and indicated that the graft was manufactured according to procedure and met all required specifications; all final product sterility and environmental monitoring test results complied.There were no non-conformances associated with the manufacture of the product.The donor records were reviewed by the medical director; the donor was confirmed to have been appropriately screened and tested in accordance with the manufacturer¿s donor suitability criteria, and was deemed eligible for transplantation.All infectious disease tests were non-reactive (compliant).The donor tissue underwent low dose pre-processing irradiation with gamma radiation within the required dosage rate.The tissue recovery organization which provided the donor tissue to the manufacturer was notified of this incident, and they have received no additional reports of infection of any type involving any other tissues procured from this donor.The manufacturer has not received any other reports of infection involving any other grafts manufactured from this lot or from this donor tissue.Based on these findings, the medical director has concluded that there is no medical evidence to indicate that the subject graft caused or contributed to the patient's infection, which occurred one month post-op.No further action is required at this time and this event is considered closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GRAFTON DBM
Type of Device
FILLER, BONE VOID, OSTEOINDUCTION (W/O HUMAN GROWTH FACTOR)
Manufacturer (Section D)
OSTEOTECH, INC (SUBSIDIARY OF MEDTRONIC)
201 industrial way west
eatontown NJ 07724
Manufacturer (Section G)
OSTEOTECH, INC (SUBSIDIARY OF MEDTRONIC)
201 industrial way west
eatontown NJ 07724
Manufacturer Contact
edward wheeler
201 industrial way west
eatontown, NJ 07724
7325422800
MDR Report Key3839463
MDR Text Key4683820
Report Number2246640-2014-00005
Device Sequence Number1
Product Code MBP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K051195
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial
Report Date 04/29/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/19/2016
Device Model NumberT43105
Device Catalogue NumberT43105
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/29/2014
Initial Date FDA Received05/29/2014
Date Device Manufactured12/31/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age00019 YR
Patient Weight98
-
-